ecancer

European Cancer Congress 2013 - News Roundup

Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology

22 Oct 2013

New antibody drug, MPDL3280A, in non-small cell lung cancer

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France

3 Oct 2013

Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy

29 Sep 2013

Results for new antibody drug in non-small cell lung cancer

Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France

29 Sep 2013

ecancerNews Highlights from August 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

8 Aug 2013

Government policy and engagement in cancer care

Dr Robert Thomas – Peter MacCallum Cancer Institute, Victoria, Australia

24 Jul 2013

Reducing lung cancer incidence and mortality worldwide

Prof David Zaridze – N.N. Blokhin Cancer Research Centre, Moscow, Russia

24 Jul 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks

11 Jul 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

Crizotinib superior to chemo for advanced ALK positive NSCLC

Dr Suresh S. Ramalingam - Emory University, Atlanta, USA

6 Jun 2013

Comment on progression free survival in lung cancer patients and the GALAXY-1 trial

Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA

3 Jun 2013

More from ecancer